A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out about the safety of adding the investigational drug
motexafin gadolinium to a standard course of chemotherapy with temozolomide for patients with
malignant glioma. Secondly, the study will determine how many patients will respond to this
treatment.